Search results
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks via Yahoo Finance· 2 hours agoApellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus...
'Green Whistle' Provides Pain Relief -- But Not in the US
Medscape· 12 hours agoJoining me today to discuss the use of methoxyflurane (Penthrox), an inhaled nonopioid analgesic for...
Earnings call: Assertio Holdings reports growth and CEO search progress By Investing.com
Investing.com· 8 hours agoAssertio Holdings (ASRT) has provided a detailed overview of their first-quarter financial...
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302
Digital Journal· 4 hours ago...the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces the submission to ethics of a trial entitled "A Phase 1, Randomized, Double-Blind, Placebo-Controlled,...
Enanta Pharmaceuticals Inc (ENTA) (Q2 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 10 hours agoQ: What doses of EDP-323 are you testing in the Phase IIa human challenge study? A: Jay Luly responded that they are testing two regimens: one with a consistent 600 mg dose
$4 million bond issued for man accused of giving fatal dose of Benadryl to 3-year-old boy
WBNS-10TV Columbus· 4 days agoA Franklin County judge issued a $4 million bond for a man who allegedly gave a 3-year-old boy a...
High-Dose Prednisone Can Reduce Rate of Pregnancy
Medscape· 3 days agoIn the first randomized controlled trial of prednisone for postvasectomy reversals, fertility researchers found that a high dose of the steroid reduced the rate of subsequent ...
Truist completes sale of insurance subsidiary; discloses notable financial shifts
Winston-Salem Journal· 19 minutes agoTruist Financial Corp. completed Tuesday the selling of the remaining 80% of its ownership of its...
AP source: J&J doses to be released, but many will be tossed
AOL· 7 days agoU.S. regulators are allowing for the release of 10 million doses of Johnson & Johnson's COVID-19...
IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financial and Strategic Developments
GuruFocus.com via Yahoo Finance· 5 hours agoThe reported loss per share of $0.53 also slightly exceeded the anticipated $0.51. Company Overview...saw significant advancements in IDEAYAs clinical programs. Noteworthy developments include ...